Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modafinil on Neurophysiological Biomarkers in Healthy Adults
NCT03616717Phase 4Completed
- Sponsor
- University of California, San Diego
- Start
- Oct 2018
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, triple-blind trial of modafinil in narcolepsy, obstructive sleep apnea (OSA) and shift work sleep disorder (SWSD) (3 arms), sponsored by University of California, San Diego. Primary endpoints: Reward Positivity at 1 year and Motivation Signal at 1 year. Started Oct 2018; status: completed.
02
Drugs
modafinil
03
Conditions
narcolepsyobstructive sleep apnea (OSA)shift work sleep disorder (SWSD)
Beyond the preview
Go deeper on NCT03616717.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03616717.